Karyopharm Therapeutics (KPTI) Amortizatization of Intangibles (2015 - 2025)

Karyopharm Therapeutics (KPTI) has 11 years of Amortizatization of Intangibles data on file, last reported at $9000.0 in Q4 2025.

• Quarterly Amortizatization of Intangibles fell 97.7% year-over-year to $9000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $410000.0 (down 83.63% YoY) and the FY2025 annual result came in at $410000.0, down 83.63% from the prior year.
• Amortizatization of Intangibles slipped to $9000.0 in Q4 2025, from $45000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q1 2023 to a low of -$664000.0 in Q1 2021.
• A 5-year average of $313850.0 and a median of $263000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2021 — Amortizatization of Intangibles slumped 5433.33% — and 2023, when it soared 2602.22%.
• Tracing KPTI's Amortizatization of Intangibles over 5 years: stood at -$138000.0 in 2021, then surged by 436.23% to $464000.0 in 2022, then soared by 120.04% to $1.0 million in 2023, then tumbled by 61.61% to $392000.0 in 2024, then tumbled by 97.7% to $9000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at $9000.0 (Q4 2025), $45000.0 (Q3 2025), and $120000.0 (Q2 2025), per Business Quant data.